Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study

Clinical trial NCT02528786 · COMPLETED

Trial details

NCT number: NCT02528786
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2015-11-19
Primary completion: 2016-04-05
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.